Apellis Pharmaceuticals, Inc.
- UEI
- K5MJXKU48NA9
- CAGE
- 5XS18
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Waltham, MA XXKJSCZRL266
-
- SAM.gov registration date
- Website
- apellis.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Aphena Pharma Solutions Holdings, Inc. | Cookeville, TN | 561910 Packaging and Labeling Services |
| Traxbel | Zaventem, Vlaams Gewest | 324110 Petroleum Refineries |
| Object Pharma Inc. | Aliso Viejo, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| (A Development Stage Company) | — | 541711 Research and Development in Biotechnology |
| Banterra Corp | Eldorado, IL | 551112 Offices of Other Holding Companies |
About the company
Apellis Pharmaceuticals, Inc. is a corporate entity registered to receive federal contract awards from the U.S. government. The company has been registered in SAM.gov since March 19, 2010, with its most recent registration expiring on July 25, 2018. As a for-profit organization, Apellis Pharmaceuticals, Inc. operates as a parent company in its business structure. While specific details about the goods or services provided to the federal government are not explicitly stated in the given information, the company's status as a pharmaceutical entity suggests it likely provides pharmaceutical products, research, or related services to government agencies.
Based on the limited information provided, it is challenging to provide a detailed description of the specific goods and services Apellis Pharmaceuticals, Inc. has provided through past prime and sub federal contract awards. The company's most recent federal contract award date is listed as June 12, 2024, which is a future date and may indicate an ongoing or upcoming contract. Without additional data on past awards, funding agencies, prime or sub partners, or set-aside designations, it is not possible to offer a comprehensive summary of the nature of work this entity performs via contracts.
The provided information does not include any details about federal contract Indefinite Delivery Vehicles (IDVs) held by Apellis Pharmaceuticals, Inc. Consequently, it is not possible to describe the types of goods or services provided under IDVs, their relation to any parent vehicles, or the agencies that have awarded task orders. More specific contract data would be required to offer insights into the company's involvement in federal IDVs and associated task orders.
Quick answers
Is Apellis Pharmaceuticals, Inc. registered in SAM.gov?
Apellis Pharmaceuticals, Inc.'s SAM.gov registration expired on July 25, 2018.
On GovTribe
See Apellis Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors